[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
April 27, 2009April 27, 2009

Editor's CorrespondenceCOMMENTS AND OPINIONS

Arch Intern Med. 2009;169(8):809-813. doi:10.1001/archinternmed.2009.81

The investigation by Leendertse et al1 confirms earlier findings that many hospital admissions related to medications (HARMs) are potentially preventable and that a substantial portion of them involve a handful of long-existing drug classes with pharmacologically predictable effects. The important implication is that clinical risk management should focus not only on new risks of new drugs but also on certain old risks of old drugs. This prompted the setup of an expert “HARM-Wrestling” Group, which has recently presented specific advice concerning 7 categories of adverse effects (ie, hemorrhage, electrolyte disturbances, fractures, disturbances of diabetic control, renal insufficiency and heart failure, constipation, and bradycardia).2

×